Transvaginal dehydroepiandrosterone: an unconventional proposal to deliver a mysterious androgen that has no receptor or target tissue using a strategy with a new name: hormone precursor replacement therapy (HPRT).

Buster, John E

Buster, John E.

Menopause ; 16(5): 858-9, 2009.

Article in En | MEDLINE | ID: mdl-19574935

Subject(s)

Dehydroepiandrosterone/deficiency; Dehydroepiandrosterone/therapeutic use; Hormone Replacement Therapy/methods; Postmenopause/drug effects; Administration, Intravaginal; Atrophy; Clinical Trials, Phase III as Topic; Dehydroepiandrosterone/metabolism; Female; Humans; Middle Aged; Postmenopause/physiology; Sexual Dysfunction, Physiological/drug therapy; Sexual Dysfunction, Physiological/etiology; Vagina/drug effects; Vagina/pathology; Zona Reticularis/drug effects; Zona Reticularis/physiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dehydroepiandrosterone / Postmenopause / Hormone Replacement Therapy Type of study: Etiology_studies Limits: Female / Humans / Middle aged Language: En Journal: Menopause Journal subject: GINECOLOGIA Year: 2009 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google